Daniel O’Day, Chairman and Chief Executive Officer at Gilead Sciences, shared a post on LinkedIn:
“Every year in January, I have the opportunity to connect with around 1500 U.S. based Gilead Sciences and Kite Pharma employees who come together to focus on the year ahead. These are the colleagues who show up every day in clinics and hospitals across the country—representing our science, earning the trust of physicians, and helping ensure that breakthroughs reach the people who need them most. Every year, every person I meet is passionate and purpose-driven and this year was no exception.
It’s a special time for the company, with up to 10 new launches ahead through 2027 and a portfolio of medicines that has never been stronger. And we couldn’t have a better team to help turn our innovation into impact.
One of the most meaningful moments for all of us was hearing from patients and caregivers—some of whom work at Gilead and Kite—as a powerful reminder of why our work matters. Thank you to everyone who shared their stories, and to all the teams who will help us do even more for patients like them in 2026.”
More posts featuring Daniel O’Day.
